June 13, 2025
NEW ORLEANS – The 26th annual New Cardiovascular Horizons (NCVH) conference brought 1,400 from across the globe to New Orleans to collaborate and share education on the diagnosis and treatment of cardiovascular diseases. Despite a national trend of declining conference attendance, NCVH saw a 10% increase in healthcare practitioner participation this year—demonstrating the conference’s continued growth, relevance, and impact in cardiovascular medicine. Held May 27-30 at The Roosevelt Hotel, the conference focused on advancing care and improving treatment outcomes across the country.
“It’s incredible to see how far this conference has come — from a small gathering to a global exchange of ideas in our 26th year. What began as a local vision has become an international mission: to learn from the brightest minds around the world and bring the very best in cardiovascular care back to our communities,” said Dr. Craig M. Walker, conference founder and interventional cardiologist, and founder of Cardiovascular Institute of the South (CIS). “That’s been the driving force behind NCVH and the growth of CIS—an achievement made possible by a dedicated team with a shared mission: to deliver the highest quality cardiovascular care possible.”
This multi-disciplinary, accredited conference featured more than 20 live cases from around the world, 215+ faculty and 50+ exhibitors. Highlights included the premier Fellows course, a record-breaking turnout for the Business of Medicine sessions, the debut of an exclusive Structural Heart Track, expanded focus on ultrasound and thermographic imaging, and the introduction of Society for Vascular Ultrasound CME credits for the American Registry of Diagnostic Medical Sonographers (ARDMS®). Additional highlights included five keynote presentations on trending topics, family practice and wound care sessions, the “Meet the Titans” networking reception, and a Mardi Gras Masquerade celebration at the Orpheum Theater in honor of its 26th year.
With 10 co-chairmen and 22 course directors, the conference lineup offered up to 25 continuing education credits for physicians of all specialties, as well as nurse practitioners, physician assistants, nurses, cath lab technicians and healthcare professionals.
Several major announcements and first-time clinical findings were unveiled at NCVH 2025. Dr. George Adams presented, for the first time in the U.S., the 36-month results of the Japan trial of SELUTION, and globally debuted 12-month data on sirolimus-eluting balloon performance in real-world peripheral artery disease (PAD) patients. Dr. Ankur Lodha, Interventional Cardiologist at CIS in Lafayette, demonstrated the first-ever use of the Boston Scientific Ranger 200 Drug-Coated Balloon. In addition, Reflow Medical announced live on stage that it had received FDA De Novo clearance for its Spur Peripheral Retrievable Stent System.
NCVH provides accredited education on late-breaking advancements in cardiovascular medicine and technology to improve the diagnosis and treatment of vascular conditions, reducing morbidity, mortality, cost and amputations. Upcoming one-day regional meetings are scheduled in Baton Rouge, Louisiana; Atlantic City, New Jersey; Lafayette, Louisiana; Fort Lauderdale, Florida; Chicago, Illinois; Nashville, Tennessee; St. Louis, Missouri; and Tampa, Florida. Registration is open for the regional meetings, as well as the 27th Annual Conference, taking place May 26-29, 2025, in New Orleans. Learn more at www.ncvh.org.